ReviewTherapeutic advances in medical oncology2018

Inhibitors targeting CDK4/6, PARP and PI3K in breast cancer: a review.

Siti Muhamad Nur Husna et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.